BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12465161)

  • 1. Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections?
    Pullman-Mooar S; Mooar P; Sieck M; Clayburne G; Schumacher HR
    J Rheumatol; 2002 Dec; 29(12):2611-4. PubMed ID: 12465161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.
    Kemper F; Gebhardt U; Meng T; Murray C
    Curr Med Res Opin; 2005 Aug; 21(8):1261-9. PubMed ID: 16083536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute local reactions after intraarticular hylan for osteoarthritis of the knee.
    Puttick MP; Wade JP; Chalmers A; Connell DG; Rangno KK
    J Rheumatol; 1995 Jul; 22(7):1311-4. PubMed ID: 7562764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
    Waddell DD; Cefalu CA; Bricker DC
    Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis.
    Marshall KW; Manolopoulos V; Mancer K; Staples J; Damyanovich A
    J Orthop Res; 2000 May; 18(3):416-25. PubMed ID: 10937628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral symmetric inflammatory reaction to hylan G-F 20 injection.
    Martens PB
    Arthritis Rheum; 2001 Apr; 44(4):978-9. PubMed ID: 11315938
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute adverse reaction to hylan G-F 20: comment on the article by Martens.
    Tomás Gil J; Lopez Mateu P; Alegre J
    Arthritis Rheum; 2003 Mar; 48(3):866; author reply 866. PubMed ID: 12632457
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictors of clinical response to intraarticular Hylan injections -- a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging.
    Anandacoomarasamy A; Bagga H; Ding C; Burkhardt D; Sambrook PN; March LM
    J Rheumatol; 2008 Apr; 35(4):685-90. PubMed ID: 18278831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of intraarticular osteoarthritis of the knee with hylan G-F 20: comment on the article by Brandt et al.
    Parenti D; Murray CW
    Arthritis Rheum; 2001 Jun; 44(6):1470-1; author reply 1473-6. PubMed ID: 11407711
    [No Abstract]   [Full Text] [Related]  

  • 10. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee.
    Bagga H; Burkhardt D; Sambrook P; March L
    J Rheumatol; 2006 May; 33(5):946-50. PubMed ID: 16652425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada.
    Lussier A; Cividino AA; McFarlane CA; Olszynski WP; Potashner WJ; De Médicis R
    J Rheumatol; 1996 Sep; 23(9):1579-85. PubMed ID: 8877928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial fluid findings in a patient after hylan GF 20 injection.
    Kwan-Morley J; Clayburne G; Schumacher HR
    J Clin Rheumatol; 2008 Apr; 14(2):120. PubMed ID: 18391685
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.
    Jüni P; Reichenbach S; Trelle S; Tschannen B; Wandel S; Jordi B; Züllig M; Guetg R; Häuselmann HJ; Schwarz H; Theiler R; Ziswiler HR; Dieppe PA; Villiger PM; Egger M;
    Arthritis Rheum; 2007 Nov; 56(11):3610-9. PubMed ID: 17968921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional outcome in knee osteoarthritis after treatment with hylan G-F 20: a prospective study.
    Goorman SD; Watanabe TK; Miller EH; Perry C
    Arch Phys Med Rehabil; 2000 Apr; 81(4):479-83. PubMed ID: 10768539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of hylan G-F 20 after knee arthroscopy in an active patient population with knee osteoarthritis.
    Zietz PM; Selesnick H
    Arthroscopy; 2008 Apr; 24(4):416-22. PubMed ID: 18375273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
    Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
    Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK).
    Clarke S; Lock V; Duddy J; Sharif M; Newman JH; Kirwan JR
    Knee; 2005 Jan; 12(1):57-62. PubMed ID: 15664879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Hylan G-F 20 and Sodium Hyaluronate in the treatment of osteoarthritis of the knee -- a prospective randomized clinical trial.
    Raman R; Dutta A; Day N; Sharma HK; Shaw CJ; Johnson GV
    Knee; 2008 Aug; 15(4):318-24. PubMed ID: 18430574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting.
    Waddell D; Rein A; Panarites C; Coleman PM; Weiss C
    Am J Manag Care; 2001 Oct; 7(10):981-91. PubMed ID: 11669362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review.
    Waddell DD; Bricker DC
    J Surg Orthop Adv; 2006; 15(1):53-9. PubMed ID: 16603113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.